Friday newspaper round-up: Barclays, Aviva, Manufacturers
The determination to find new blockbuster drugs has encouraged GlaxoSmithKline to bid $2.6 billion for a company that it admits has uncertain prospects. GSK has offered to buy its long-term partner Human Genome Sciences for $13 a share, an 81 per cent premium to the previous day's price. The compani
Read more